BioRestorative Therapies, Inc.
US ˙ NasdaqCM ˙ US0906556065

Introduction

This page provides a comprehensive analysis of the known insider trading history of Francisco Silva. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Francisco Silva has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:BRTX / BioRestorative Therapies, Inc. VP of Research and Development, Director 155,759
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Francisco Silva. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BRTX / BioRestorative Therapies, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BRTX / BioRestorative Therapies, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-04-09 BRTX Silva Francisco 6,600 1.2500 6,600 1.2500 8,250 303 2.4700 8,052 97.60
2024-04-08 BRTX Silva Francisco 476 1.1300 476 1.1300 538
2024-04-08 BRTX Silva Francisco 1,232 1.1700 1,232 1.1700 1,441
2023-08-31 BRTX Silva Francisco 4,954 2.2200 4,954 2.2200 10,998
2023-03-31 BRTX Silva Francisco 747 3.5600 747 3.5600 2,659
2022-11-21 BRTX Silva Francisco 943 2.6162 943 2.6162 2,467
2022-10-12 BRTX Silva Francisco 725 3.3884 725 3.3884 2,457
2022-10-11 BRTX Silva Francisco 806 3.6886 806 3.6886 2,973
2022-08-29 BRTX Silva Francisco 2,816 3.2130 2,816 3.2130 9,048
2022-08-29 BRTX Silva Francisco 307 3.3190 307 3.3190 1,019
2022-08-26 BRTX Silva Francisco 2,600 3.3500 2,600 3.3500 8,710
2021-11-19 BRTX Silva Francisco 4,000 6.6565 4,000 6.6565 26,626
2021-11-16 BRTX Silva Francisco 3,826 6.8300 3,826 6.8300 26,132
2021-11-16 BRTX Silva Francisco 4,000 6.6250 4,000 6.6250 26,500
2019-09-04 BRTX Silva Francisco 2,500 0.2355 1 942.0000 589
2019-09-04 BRTX Silva Francisco 18,455 0.2400 5 960.0000 4,429
2019-08-30 BRTX Silva Francisco 2,500 0.2600 1 1,040.0000 650
2019-08-30 BRTX Silva Francisco 5,000 0.2799 1 1,119.6000 1,400
2019-08-30 BRTX Silva Francisco 10,500 0.2800 3 1,120.0000 2,940
2019-08-26 BRTX Silva Francisco 3,500 0.2900 1 1,160.0000 1,015
2019-08-26 BRTX Silva Francisco 4,000 0.2500 1 1,000.0000 1,000
2019-08-22 BRTX Silva Francisco 8,446 0.2304 2 921.6000 1,946
2019-08-22 BRTX Silva Francisco 8,928 0.2800 2 1,120.0000 2,500
2017-02-09 BRTX Silva Francisco 1,800 4.3800 0 17,520.0000 7,884
2017-02-02 BRTX Silva Francisco 2,250 4.2500 1 17,000.0000 9,562
2014-06-11 BRTX Silva Francisco 20 7.6000 0 15,276.0000 152
2014-06-10 BRTX Silva Francisco 25 7.6000 0 15,276.0000 190
2013-12-26 BRTX Silva Francisco 100 10.4000 0 20,904.0000 1,040
2013-07-17 BRTX Silva Francisco 50 10.4000 0 20,904.0000 520

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BRTX / BioRestorative Therapies, Inc. Insider Trades
Insider Sales BRTX / BioRestorative Therapies, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BRTX / BioRestorative Therapies, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2022-08-26 BRTX Silva Francisco 3,958 3.3880 3,958 3.3880 13,410 357 2.3600 -4,068 -30.34

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BRTX / BioRestorative Therapies, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Francisco Silva as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-04-10 2024-04-09 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 6,600 155,759 4.42 1.25 8,250 194,699
2024-04-10 2024-04-08 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 1,232 149,159 0.83 1.17 1,441 174,516
2024-04-10 2024-04-08 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 476 147,927 0.32 1.13 538 167,158
2024-03-20 2024-03-18 4 BRTX BioRestorative Therapies, Inc.
Common Stock
F - Taxes -17,193 147,451 -10.44 1.39 -23,898 204,957
2023-08-31 2023-08-31 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 4,954 164,644 3.10 2.22 10,998 365,510
2023-04-04 2023-03-31 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 747 159,690 0.47 3.56 2,659 568,496
2023-03-22 2023-03-20 4 BRTX BioRestorative Therapies, Inc.
Common Stock
F - Taxes -6,729 158,943 -4.06 2.92 -19,649 464,114
2023-02-28 2023-02-18 4 BRTX BioRestorative Therapies, Inc.
Common Stock
F - Taxes -374 165,672 -0.23 2.99 -1,118 495,359
2022-11-21 2022-11-21 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 943 166,046 0.57 2.62 2,467 434,410
2022-10-12 2022-10-11 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 806 164,378 0.49 3.69 2,973 606,325
2022-10-12 2022-10-12 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 725 165,103 0.44 3.39 2,457 559,435
2022-09-09 2022-08-29 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 307 12,136 2.60 3.32 1,019 40,279
2022-09-09 2022-08-29 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 2,816 163,572 1.75 3.21 9,048 525,557
2022-09-09 2022-08-26 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 2,600 160,756 1.64 3.35 8,710 538,533
2022-09-09 2022-08-26 4 BRTX BioRestorative Therapies, Inc.
Common Stock
S - Sale -3,958 158,156 -2.44 3.39 -13,410 535,833
2022-06-15 2022-06-14 4 BRTX BioRestorative Therapies, Inc.
Common Stock
A - Award 263 162,114 0.16 3.78 993 612,369
2022-06-08 2022-06-07 4 BRTX BioRestorative Therapies, Inc.
Common Stock
A - Award 565 161,851 0.35 4.65 2,627 752,494
2022-03-22 2022-03-18 4 BRTX BioRestorative Therapies, Inc.
Common Stock
A - Award 12,438 161,286 8.36
2021-11-22 2021-11-19 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 4,000 11,829 51.09 6.66 26,626 78,740
2021-11-16 2021-11-16 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 4,000 7,829 104.47 6.62 26,500 51,867
2021-11-16 2021-11-16 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 3,826 3,829 127,533.33 6.83 26,132 26,152
2021-11-08 2021-11-04 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 42,059 42,059
2021-11-08 2021-11-04 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 293,479 293,479
2021-11-08 2021-11-04 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -293,479 0 -100.00
2021-03-19 2021-03-18 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 1,173,917,974 1,173,917,974
2021-03-19 2021-03-18 4 BRTX BioRestorative Therapies, Inc.
Common Stock
A - Award 586,958,987 595,390,616 6,961.39
2020-11-24 2020-11-23 4 BRTX BioRestorative Therapies, Inc.
Common Stock
J - Other 8,375,671 8,431,629 14,967.78
2019-09-06 2019-09-04 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 18,455 55,958 49.21 0.24 4,429 13,430
2019-09-06 2019-09-04 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 2,500 37,503 7.14 0.24 589 8,832
2019-09-03 2019-08-30 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 10,500 35,003 42.85 0.28 2,940 9,801
2019-09-03 2019-08-30 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 5,000 24,503 25.64 0.28 1,400 6,858
2019-09-03 2019-08-30 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 2,500 19,503 14.70 0.26 650 5,071
2019-08-28 2019-08-26 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 4,000 17,003 30.76 0.25 1,000 4,251
2019-08-28 2019-08-26 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 3,500 12,116 40.62 0.29 1,015 3,514
2019-08-23 2019-08-22 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 8,928 13,003 219.09 0.28 2,500 3,641
2019-08-23 2019-08-22 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 8,446 8,616 4,968.24 0.23 1,946 1,985
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 100,000 100,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -100,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 80,000 80,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -80,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 60,000 60,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -60,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 25,000 25,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -25,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 37,500 37,500
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -37,500 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000 2,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000 2,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -2,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -2,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000 2,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -2,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 12,500 12,500
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -12,500 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 5,000 5,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -5,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 4,000 4,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 4,000 4,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -4,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -4,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 5,500 5,500
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -5,500 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 1,000 1,000
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -1,000 0 -100.00
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 150 150
2019-03-26 2019-03-25 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -150 0 -100.00
2018-10-31 2018-10-29 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 100,000 100,000
2017-07-14 2017-07-12 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 80,000 80,000
2017-03-01 2017-02-09 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 1,800 4,075 79.12 4.38 7,884 17,848
2017-03-01 2017-02-02 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 2,250 2,275 9,000.00 4.25 9,562 9,669
2017-03-01 2014-06-11 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 20 170 13.33 7.60 152 1,292
2017-03-01 2014-06-10 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 25 25 7.60 190 190
2017-03-01 2013-12-26 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 100 150 200.00 10.40 1,040 1,560
2017-03-01 2013-07-17 4 BRTX BioRestorative Therapies, Inc.
Common Stock
P - Purchase 50 50 10.40 520 520
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 25,000 25,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -25,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 37,500 37,500
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -37,500 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000 2,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000 2,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -2,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -2,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000 2,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -2,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 12,500 12,500
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -12,500 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 5,000 5,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -5,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 4,000 4,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 4,000 4,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -4,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -4,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 5,500 5,500
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -5,500 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 1,000 1,000
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -1,000 0 -100.00
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 150 150
2017-02-15 2017-02-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
D - Sale to Issuer -150 0 -100.00
2016-06-14 2016-06-10 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 60,000 60,000
2015-12-23 2015-12-22 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 25,000 25,000
2014-10-27 2014-10-23 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 750,000 750,000
2014-04-16 2014-04-14 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 40,000 40,000
2014-03-14 2014-03-12 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 40,000 40,000
2014-02-20 2014-02-18 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 250,000 250,000
2013-10-08 2013-10-04 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 100,000 100,000
2012-02-14 2012-02-10 4 BRTX BioRestorative Therapies, Inc.
Stock Option
A - Award 2,000,000 2,000,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)